1. Home
  2. CRC vs EWTX Comparison

CRC vs EWTX Comparison

Compare CRC & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

SELL

Current Price

$46.98

Market Cap

4.8B

Sector

Energy

ML Signal

SELL

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

SELL

Current Price

$43.63

Market Cap

4.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRC
EWTX
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.3B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CRC
EWTX
Price
$46.98
$43.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
13
Target Price
★ $74.08
$55.42
AVG Volume (30 Days)
887.3K
★ 1.5M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 3.48%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 8.86
Revenue
★ $3,669,000,000.00
N/A
Revenue This Year
$2.35
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.24
Revenue Growth
★ 14.73
N/A
52 Week Low
$43.25
$19.76
52 Week High
$71.98
$48.78

Technical Indicators

Market Signals
Indicator
CRC
EWTX
Relative Strength Index (RSI) 34.08 55.13
Support Level $45.45 $37.22
Resistance Level $55.21 $47.64
Average True Range (ATR) 1.94 3.24
MACD -0.38 0.67
Stochastic Oscillator 15.02 60.60

Price Performance

Historical Comparison
CRC
EWTX

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: